GINGERA MIDLIFE, UNDERSTOOD
← The reading room
Sleep & energy · 17 MIN READ

Insomnia and Hormonal Fluctuations in Women: Stolen Sleep

Full original restored

Night waking may relate to hot flashes, stress, routine, mood or other health factors. A brief log can make a future conversation more specific.

Editorial image
In this article
Complete manuscript restored from the archive, with a full English translation. Original medical claims have been preserved for review; medical and regional terminology review remain pending. This is educational reading, not individual medical advice.

At a gathering with friends my age last week, our coffees had barely arrived before the conversation somehow turned to "none of us has been sleeping well lately." One said her mind would not stop once she lay down; another kept waking in the night and lay awake until dawn. Someone else smiled ruefully: "I am exhausted, but my body refuses to sleep." This scene is hardly unusual. In a health report jointly released by Weibo and IQVIA, "sleep regulation" was listed among six health topics with audiences in the tens of billions, and a discussion under #WhichIsMoreHarmfulSleepingLessOrGoingToBedLate# reached 130 million views. When "I cannot sleep" becomes a shared experience for a generation, we first need to distinguish what comes from emotions, what comes from hormones, and what needs a doctor's attention.

This article aims to clarify "insomnia and hormonal fluctuations in women": how common it is, exactly how hormones disrupt sleep, what stolen sleep costs the body, and—most importantly—what you can do yourself and what requires a medical consultation.

1. Sleep problems are not "making a fuss": how common is insomnia in women over 40?

Original article illustration

A scene from Bhutan: Punakha Dzong and the river valley

First, set aside the self-doubt of "Am I being too fragile?" Sleep disorders are already common in women, and perimenopause is a recognized "high-incidence window." Findings from multiple studies are fairly consistent: sleep disorders affect approximately 16%–47% of perimenopausal women, rising further to 35%–60% after menopause. Among women aged 40–60, the estimated prevalence of insomnia—disturbed sleep accompanied by distress or functional impairment—is as high as 38%–60%【Research】.

More specific studies provide further detail: a survey of 6079 middle-aged women found a perimenopausal insomnia prevalence of approximately 41.7% using the Pittsburgh Sleep Quality Index screening threshold of PSQI≥5. In another study of 982 perimenopausal women, 26% met the diagnosis of chronic insomnia "lasting more than six months," with "difficulty maintaining sleep" (repeatedly waking at night) the most common problem【Research】. An American Academy of Sleep Medicine (AASM) survey also found that among women aged 45–64, 37% woke frequently at night, 35% had sleep interrupted by hot flashes and night sweats, 29% experienced daytime fatigue, and 27% had difficulty falling asleep. Only 6% said their sleep had "not changed"【Association】.

38–60%

Prevalence of insomnia among women aged 40–60【Research】

1.5 times

Women's insomnia risk compared with men's【Research】

2.7 times

Risk of sleep disorders in those with hot flashes【Research】

An often-overlooked fact is that women's risk of insomnia is approximately 1.5 times men's, and perimenopause pushes that curve higher still【Research】. Also worth remembering is that hot flashes affect 60%–80% of perimenopausal women. A meta-analysis found that women with hot flashes had 2.7 times the risk of sleep disorders compared with those without them【Research】. In other words, behind many cases of "I cannot sleep" is a real physiological cause, rather than a personality problem.

A central point to understand

"I have not been sleeping well recently" does not mean "I have insomnia disorder." In medicine, the term "insomnia disorder" is generally used when sleep difficulties persist, cause daytime fatigue or emotional or functional impairment, and continue beyond a certain duration (usually about three months). Before then, the problem may signal a combination of hormonal fluctuations, stress, and lifestyle habits. That signal deserves attention, but do not rush to label yourself.

2. How exactly do hormones "disrupt" sleep?

Estrogen and progesterone, the two hormones that accompany women throughout life, both directly participate in sleep regulation. During perimenopause, their "erratic decline"—not a steady fall, but repeated highs and lows—interferes with sleep through several pathways at once.

Estrogen: regulating temperature and the "wakefulness switch"

Estrogen acts directly on sleep-regulating nuclei in the hypothalamus and the body's "master clock" (the suprachiasmatic nucleus), and affects the serotonin system, which is essential to the sleep–wake cycle. It also suppresses "wake-promoting" neurotransmitters such as histamine, norepinephrine, and orexin, thereby shortening the time needed to fall asleep and reducing nighttime awakenings. When estrogen fluctuates and falls, the brain becomes sensitive to small changes in core body temperature and the hypothalamic thermoregulatory center becomes disrupted, producing hot flashes. A single hot flash can abruptly "heat" you awake during sleep【Research】.

Progesterone: a natural "sedative"

Progesterone is metabolized into a neuroactive substance called allopregnanolone, which positively modulates GABA receptors in the brain—the very targets of many anti-anxiety and sleep medications. In other words, progesterone itself is a mild natural sedative. During perimenopause, ovulation becomes less frequent and progesterone levels fall or may be absent. The endogenous "GABAergic sleep-stabilizing" effect weakens accordingly, making it easier for the brain to remain "awake" at night【Research】.

Rhythm and breathing: two overlooked pieces of the puzzle

Estrogen also helps regulate melatonin secretion by the pineal gland and circadian rhythms. After menopause, nighttime melatonin secretion falls and circadian rhythms weaken, resulting in difficulty falling asleep, early waking, and disrupted schedules. Breathing is a less obvious factor: progesterone mildly stimulates breathing and dilates the upper airway, while estrogen helps maintain upper-airway muscle tone. Hormonal withdrawal combined with central obesity significantly increases women's postmenopausal risk of snoring and obstructive sleep apnea (OSA), bringing it close to that of men of the same age【Research】.

A crucial detail

Research repeatedly suggests that the degree and pattern of hormonal fluctuation are more strongly related to sleep disorders than the "absolute hormone level." This is why many women's sleep problems quietly appear well before periods become irregular, during the stage when hormonal swings are most pronounced. It is not simply a matter of "a low number," but of "a system being shaken."

3. What does the body pay when sleep is stolen?

Original article illustration

A portrait from Bhutan: a young woman's traditional clothing and everyday life

Some people think, "It is only a little less sleep; I can push through." But objective sleep-monitoring studies using polysomnography (PSG) provide hard data: women with perimenopausal insomnia sleep approximately 43.5 minutes less in total than controls on average, and nearly half the sample sleeps less than 6 hours a day. Their sleep is "lighter" and more fragmented, the temporal organization of deep sleep is disrupted, and EEG recordings can even detect persistent signals of "physiological hyperarousal"【Research】.

The cost of long-term poor sleep extends far beyond "feeling tired the next day":

  • Cardiovascular health: Prolonged sympathetic activation increases the risks of hypertension, arrhythmia, and atherosclerosis;
  • Metabolism: Insulin sensitivity falls, while risks of obesity, type 2 diabetes, and dyslipidemia rise;
  • Mood and cognition: Risks of anxiety and depression rise markedly, while memory and attention decline;
  • Quality of life: Daytime fatigue undermines work and social functioning.

This is why mainstream guidelines emphasize that although perimenopausal insomnia is common, it should not be dismissed as "normal aging." It is often an early warning signal for cardiovascular, metabolic, and mental health problems.

It is also why doctors often assess sleep and mood together. Anxiety makes falling asleep difficult, while prolonged sleep deprivation amplifies anxiety; the two cause and reinforce each other. Identifying this two-way chain is often more useful than simply "forcing yourself to relax." It reminds you that a sleep problem is never just about "sleep," but is a signal involving both body and mind.

4. Which signs mean it is time for a medical consultation?

Occasional poor sleep is normal. In the following situations, however, seek care proactively rather than continuing to endure it or buying melatonin or sleeping pills yourself:

  • Insomnia lasting more than three months, or clearly affecting daytime mood, work, or social life;
  • Worsening snoring, waking gasping at night, or uncontrollable daytime sleepiness: Consider sleep apnea, particularly after menopause or with weight gain;
  • Persistent low mood or anxiety: Sleep and mood often form a two-way vicious cycle;
  • Severe hot flashes and night sweats: If sleep fragmentation is driven mainly by vasomotor symptoms, the management approach will differ;
  • Other accompanying symptoms: Palpitations, weight loss, or thyroid-related features, for example, require thyroid and other endocrine disorders to be ruled out first.

"Which specialty should I see first?"

For sleep problems related to female hormonal fluctuations, gynecology or endocrinology can be a starting point. If the main problem is longstanding difficulty falling or staying asleep, or significant snoring is present, sleep medicine or respiratory medicine is more directly relevant. When emotional problems predominate, psychiatry, psychology, or psychological counseling is equally important. Multidisciplinary collaboration is often needed in practice—another indication that sleep problems cannot be solved simply by "lying down earlier."

5. Start without medication: what you can do to "stabilize sleep"

Original article illustration

A scene from Bhutan: Thimphu city and traditional architecture

First, some good news: insomnia caused by hormonal fluctuations is not "irreversible." Longitudinal follow-up shows that approximately four to five in ten women experience natural improvement in insomnia within several years after menopause. More importantly, the right interventions can significantly accelerate this process. The accepted principle of "stepped treatment" is clear: start with non-drug approaches and move up step by step.

First line: behavioral and non-drug treatments (the preferred approach). The strongest evidence supports cognitive behavioral therapy for insomnia (CBT-I). This is not simply "talking about your worries," but a structured program including sleep restriction, stimulus control, sleep hygiene education, and cognitive restructuring. In clinical trials, approximately 70% of menopausal women who completed CBT-I no longer met insomnia criteria after 8 weeks, rising to about 84% at 6 months, with benefits remaining stable a year later. By comparison, remission with sleep health education alone was only about 24%–43%【Research】. CBT-I also breaks the conditioned insomnia cycle of "the more I fear not sleeping, the more awake I become," without producing medication dependence.

Beyond CBT-I, sleep hygiene is the foundation: keep a fixed waking time (including weekends), maintain a cool bedroom (about 18–20℃), use breathable, moisture-wicking bedding, exercise regularly while avoiding vigorous activity before bed, limit caffeine and alcohol from the afternoon onward, and reduce screen use for half an hour to an hour before bed. One small tip: a warm bath 60–90 minutes before bedtime dilates skin blood vessels, which actually speeds the subsequent fall in core temperature and helps sleep onset.

The "second and third lines" on the treatment ladder

If first-line measures do not provide enough relief, the guideline ladder is: second line (non-hormonal medication)—examples include low-dose prolonged-release melatonin for circadian rhythm disturbances (with relatively substantial evidence in people over 55 and no addictive potential), gabapentin for hot-flash-related insomnia, and orexin receptor antagonists with relatively little daytime residual effect. Long-term benzodiazepine use is specifically not recommended because of dependence, falls, and cognitive impairment risks. Third line (hormone therapy, or MHT)—only for moderate-to-severe hot-flash-related insomnia when the first two lines have been insufficient and no contraindications are present, usually preferring transdermal estrogen plus micronized progesterone (with a relatively lower thrombosis risk)【Research】【Association】.

6. A rational understanding of menopausal hormone therapy (MHT)

Many women feel both hopeful and fearful about hormones. The boundaries need to be clear: for sleep interruption driven primarily by hot flashes and night sweats, multiple randomized controlled trials show that MHT (menopausal hormone therapy) effectively reduces hot-flash frequency and severity and improves subjective and objective sleep. It is one of the interventions with the strongest evidence for this group【Research】. At the same time, remember three things:

  • It is not a "routine medication" for insomnia: Without significant vasomotor symptoms, MHT is not recommended as first-line treatment for insomnia;
  • Risks and benefits must be individualized: Large studies such as the Women's Health Initiative (WHI) indicate that MHT reduces menopausal symptoms and osteoporotic fracture risk, but offers no long-term cardiovascular benefit and is confirmed to increase breast cancer risk. It is generally contraindicated in people with a history of breast cancer, thrombosis, or severe liver disease;
  • There are limits to use: Professional societies recommend using the lowest effective dose for no more than approximately five years, with regular reassessment of whether continuation is needed【Association】.

One sentence to put this into action

Whether MHT suits you, which regimen to use, and for how long must be decided after a doctor comprehensively assesses your personal history, especially breast cancer, thrombosis, liver disease, and family history. It is "one specific option among the available choices," not "a tonic to take whenever you sleep badly." Retaining your right to be informed, then making a shared decision with your doctor, is the sound approach.

7. Common misconceptions, explained

Misconception one: Poor sleep means "overthinking or making a fuss."

False. Perimenopausal hormonal fluctuations disrupt sleep through clear physiological mechanisms, and women already have a higher insomnia risk than men. Acknowledging it as a real problem comes before managing it properly.

Misconception two: Hormone-related insomnia "cannot be treated" and must simply be endured.

False. Approximately four to five in ten women improve naturally within several years after menopause, and interventions such as CBT-I can substantially accelerate improvement. It is not an irreversible sentence.

Misconception three: Taking sleeping pills immediately causes dependence, so they must never be used.

Short-term use during an acute phase under medical supervision is common practice. However, prolonged self-directed benzodiazepine use does carry dependence and fall risks; CBT-I and non-hormonal approaches should be prioritized.

Misconception four: Buying melatonin yourself and taking it long term is safest.

Melatonin is not a "harmless supplement." Low-dose prolonged-release formulations have evidence in specific populations, but long-term, high-dose use without assessment is not recommended. Other causes need to be ruled out first.

Misconception five: Snoring just means "sleeping soundly."

Women's risk of sleep apnea rises after menopause. If snoring accompanies waking gasping at night or uncontrollable daytime sleepiness, investigate OSA rather than dismissing it.

Misconception six: Only a full 8 hours counts as "sleeping well."

Sleep needs vary widely; 7–9 hours falls within the normal range. What matters is "whether sleep restores you." If you sleep long enough but remain fatigued and inattentive by day, consider poor sleep quality or sleep apnea rather than simply extending time in bed.

A "sleep and hormones diary" template (to bring to your doctor)

  • Schedule: bedtime, approximate sleep-onset time, number and duration of nighttime awakenings, and waking time;
  • Sleep quality: rate it from 1–10 and note whether "sleep feels as if I have not slept";
  • Accompanying symptoms: hot flashes, night sweats, palpitations, anxiety, and pain;
  • If still menstruating: record the cycle phase (such as menstruation or around ovulation);
  • Lifestyle variables: caffeine/alcohol, exercise, stressful events, and recent medication use.

Keeping records for 4–8 consecutive weeks before your appointment is far more useful than vague descriptions such as "I keep sleeping badly lately."

8. Seven questions you may have

Original article illustration

A scene from Bhutan: Himalayan valleys and rural landscapes

  1. I keep waking at night and struggle to return to sleep. Is it hormonal?

Hormones are quite likely to be one factor, especially if you also have hot flashes or increasingly irregular periods. But anxiety, thyroid problems, snoring, and chronic pain can cause similar symptoms. Do not diagnose yourself; keep a diary and let a doctor distinguish the causes.

  1. What is CBT-I, and where can I access it?

It is cognitive behavioral therapy for insomnia: a structured behavioral and cognitive intervention with strong evidence and no dependence. It can be completed through a hospital sleep or psychology service or an accredited online course, usually over 6–8 weeks.

  1. Can I take melatonin long term?

Long-term self-directed use without assessment is not recommended. Low-dose prolonged-release formulations have evidence in certain older populations, but a doctor must determine whether they suit you, and they do not address every type of insomnia.

  1. I heard hormone therapy improves sleep. Can I start it directly?

MHT is only a third-line option in specific circumstances (moderate-to-severe hot-flash-related insomnia without contraindications). It requires a comprehensive medical assessment of benefits and risks and is certainly not something to "take whenever you sleep badly."

  1. Does lowering the bedroom temperature really help?

There is a physiological basis for it. A cool environment (about 18–20℃) supports the fall in core temperature needed for sleep onset and is particularly helpful for frequent hot flashes and night sweats. Breathable bedding makes it more effective.

  1. What is the relationship between exercise and sleep?

Regular daytime exercise helps stabilize sleep, but vigorous exercise before bed may have the opposite effect. Scheduling exercise during the day is one of the most worthwhile "sleep-promoting" habits.

  1. Will poor sleep get better on its own?

Some women improve as hormonal fluctuations settle, but delay may allow acute insomnia to become chronic, conditioned, and persistent. Earlier assessment and intervention support faster recovery.

9. A final thought: hormonal fluctuations are not an "irreversible" sentence

Return to the gathering at the beginning. As everyone takes turns describing "not sleeping well lately," the point to remember is not "our generation of middle-aged people is too fragile." It is that sleep difficulties are so common in women over 40 precisely because real hormonal changes, overlooked breathing problems, and accumulated metabolic stress lie behind them. They deserve serious attention rather than being dismissed with "stop staying up so late."

The good news is equally real: this is not an irreversible fate. From CBT-I and sleep hygiene to checking for thyroid disease and OSA, and carefully discussing MHT with a doctor when needed, the path is clear. Your role is to turn "I feel" into "I record, seek care, and participate in decisions." Keep your right to be informed, and leave treatment to evidence and a doctor you trust.

This issue's takeaway

Poor sleep is not making a fuss, and endurance is not your only option. Bring your sleep diary to a proper healthcare facility for an assessment that distinguishes emotions, hormones, and disease. Make shared decisions with your doctor about MHT or any other approach.

Disclaimer

: This article is for health education, based on public guidelines, reviews, and published literature. It cannot replace an in-person diagnosis or individualized advice from a licensed physician. Whether CBT-I, medication, or menopausal hormone therapy (MHT) is needed should be determined by your treating doctor's comprehensive assessment of your personal history. Prevalence and remission rates cited here come from studies with different populations and designs and are heterogeneous. These figures only provide context for understanding risk and are not a basis for self-diagnosis. MHT has contraindications and risks; do not self-medicate.

A quick literature review for physician readers

Original article illustration

A scene from Bhutan: mountain settlements and natural scenery

  • Epidemiology: sleep disorder prevalence is 16%–47% in perimenopause and 35%–60% after menopause; insomnia affects 38%–60% of women aged 40–60. Among 6079 middle-aged women, approximately 41.7% had insomnia at PSQI≥5; among 982 perimenopausal women, 26% met chronic insomnia criteria (DSM-IV; sleep-maintenance difficulty was most common). SWAN: 38% of women aged 40–55 reported sleep difficulties, compared with 45.4% in late perimenopause and 47.6% after surgical menopause. AASM: 37% of women aged 45–64 woke frequently at night and 35% had sleep interrupted by hot flashes/night sweats. Women's insomnia risk is approximately 1.5 times men's. Hot flashes affect 60%–80% of perimenopausal women【Research】【Association】.
  • Mechanisms: estrogen regulates sleep and temperature via hypothalamic sleep nuclei/SCN, the 5-HT system, and suppression of arousal neurotransmitters (histamine, NE, orexin, DA). The progesterone metabolite allopregnanolone positively modulates GABA-A receptors and has a sedative effect. Estrogen withdrawal narrows the thermoneutral zone, with hot flashes disrupting NREM/REM sleep. Nighttime melatonin decreases and circadian rhythms weaken after menopause. Progesterone/estrogen deficiency combined with central obesity raises OSA risk. The degree of fluctuation is more strongly associated with sleep disorders than the absolute level【Research】.
  • Sleep architecture: women with perimenopausal insomnia had approximately 43.5 minutes less total PSG sleep on average, with nearly half the sample sleeping <6h. Increased light sleep, disrupted deep-sleep organization, and elevated NREM beta power suggest physiological hyperarousal (Baker and colleagues, UCSF research)【Research】.
  • CBT-I: in an RCT of menopausal women, remission was approximately 70% at 8 weeks and 84% at 6 months, outperforming sleep education alone (24%–43%). McCurry 2019 (Sleep) RCT showed benefits lasting to 12 months without directly changing hot-flash frequency【Research】.
  • Stepped treatment (JCM 2025 narrative review): first-line non-drug treatment (CBT-I preferred); second-line non-hormonal medication (low-dose prolonged-release melatonin, gabapentin, orexin receptor antagonists; long-term benzodiazepines not recommended); third-line MHT limited to moderate-to-severe hot-flash-related insomnia without contraindications, preferably transdermal estrogen + micronized progesterone【Research】.
  • MHT evidence and risks: strongest evidence for sleep interruption associated with moderate-to-severe VMS. WHI indicates reduced menopausal symptoms and fracture risk, no long-term cardiovascular benefit, and increased breast cancer risk. NAMS recommends the lowest effective dose for no more than approximately 5 years; a history of breast cancer, thrombosis, or severe liver disease is a contraindication【Research】【Association】.
  • Harms: long-term sleep disorders are associated with cardiovascular problems (hypertension, stroke), metabolic problems (reduced insulin sensitivity, obesity, T2DM, dyslipidemia), anxiety/depression, and cognitive decline【Research】.

Note: The above are quick-reading leads for professional readers. Clinical decisions should refer back to the original literature and latest guidelines. The main educational text has avoided directly using specialist terminology wherever possible to make it accessible to the public.

Supplementary research and limits of the evidence

  • AASM recommends cognitive behavioral therapy for chronic insomnia; menopausal hot flashes, mood changes, and sleep apnea should also be included in the differential diagnosis.
  • The NAMS 2022 position statement holds that hormone therapy should be discussed individually according to age, time since menopause, and risks and benefits; laboratory results alone cannot determine its use.
  • Several consecutive weeks of sleep records help a doctor identify triggers and develop a plan more than a single subjective score does.

International literature and data comparison

Source Conclusions it can support Relationship to the article's figures and tables
AASM clinical guideline on CBT-I for chronic insomnia CBT-I is first-line treatment for chronic insomnia Corresponds to the diagram of insomnia causes and stepped interventions
NAMS 2022 MHT position statement MHT requires consideration of age, time since menopause, and risks and benefits Supports the evidence boundaries in discussions of hot flashes, sleep, and MHT
Systematic reviews of menopause and sleep Hot flashes, mood, and sleep apnea may jointly affect sleep Corresponds to symptom-proportion figures; does not establish a single hormonal cause
Editorial recordClinical review pending

Sources and review scope

Editorial author
Gingera Editorial
Clinical reviewer
Not yet assigned
Citation date check
Pending; source publication dates are not recorded here.
Risk note
Moderate: avoid attributing sleep changes solely to menopause or recommending medication.

Questions for the clinical reviewer

  • Sleep changes have multiple possible contributors.
  • Persistent impairment warrants appropriate assessment; this page is not an insomnia treatment plan.
Report a content issue

Do not include health details, names, contact information or medical records. This report is sent to the editorial team.

This record lists review questions and citations. It does not mean a clinician has reviewed or approved the article.

Published correction log

  1. Loading correction history…
SOURCE NOTES

Read the source material

The original archive manuscript is restored above. These additional references offer context; their inclusion does not constitute medical validation of every original claim. Clinical and regional terminology review are pending.

GINGERA / COMMUNITY

A good question starts a conversation.

Explore a related editorial discussion. Reading is open to everyone; posting and replying require a free reader account.

Discuss sleep and energy